Evidence map›Paper›PMID 33619327›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2021

Addiction as a brain disease revised: why it still matters, and the need for consilience.

Markus Heilig, James MacKillop, Diana Martinez, Jürgen Rehm, Lorenzo Leggio, Louk J M J Vanderschuren

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07001371 (Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study), which is not on this map. Cited by 97 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 8 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07001371 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study

TypeinterventionalSponsorLoma Linda UniversityRan2026 to 2027Enrolled54ConditionsCannabis Use Disorder, Stimulant Use Disorder, Opioid Use Disorder, Tobacco Use DisorderArmsEmotional Brain Training, Standard addiction counseling and medical therapy
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 8 syntheses or guidelines pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Acute effects of alcohol on social and personal decision making.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Trial
  12. Article
  13. Article
  14. A manifesto for theoretical innovation.Addiction (Abingdon, England) · 2026
    Article
  15. Observational
  16. The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  17. Article
  18. Anterior Insula Activity during Alcohol and Social Reward Self-Administration and Choice in Male and Female Rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 6 countries.

Markus HeiligCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. markus.heilig@liu.se.
James MacKillopPeter Boris Centre for Addictions Research, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0003-4118-9500
Diana MartinezNew York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.
Jürgen RehmInstitute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-5665-0385
Lorenzo LeggioClinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7284-8754
Louk J M J VanderschurenDepartment of Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-5379-0363
Centre for Addiction and Mental Health · CAColumbia University · USHomewood Research Institute · CALinköping University · SENational Institute on Drug Abuse · USUtrecht University · NL

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIADA000635 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI LEGGIO, LORENZO · 2020 to 2025
$15.2M
From the Scanner to the Clinic: Patient Oriented Research and MentorshipK24DA050087 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Diana M Martinez · 2020 to 2026
$603k
NIDA NIH HHS K24 DA050087
6 · The paper itself

Abstract

The view that substance addiction is a brain disease, although widely accepted in the neuroscience community, has become subject to acerbic criticism in recent years. These criticisms state that the brain disease view is deterministic, fails to account for heterogeneity in remission and recovery, places too much emphasis on a compulsive dimension of addiction, and that a specific neural signature of addiction has not been identified. We acknowledge that some of these criticisms have merit, but assert that the foundational premise that addiction has a neurobiological basis is fundamentally sound. We also emphasize that denying that addiction is a brain disease is a harmful standpoint since it contributes to reducing access to healthcare and treatment, the consequences of which are catastrophic. Here, we therefore address these criticisms, and in doing so provide a contemporary update of the brain disease view of addiction. We provide arguments to support this view, discuss why apparently spontaneous remission does not negate it, and how seemingly compulsive behaviors can co-exist with the sensitivity to alternative reinforcement in addiction. Most importantly, we argue that the brain is the biological substrate from which both addiction and the capacity for behavior change arise, arguing for an intensified neuroscientific study of recovery. More broadly, we propose that these disagreements reveal the need for multidisciplinary research that integrates neuroscientific, behavioral, clinical, and sociocultural perspectives.

Indexed as

Behavior, AddictiveBrain DiseasesSubstance-Related DisordersBrainHumansReinforcement, Psychology

Identifiers

PMID33619327
PMCPMC8357831
OpenAlexW3129328254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.